Exploring Newer Strategies for Treating Chronic Noninfectious Uveitis: A Mix and Match Approach
This session will examine the evidence for biologic immunomodulatory agents and intravitreal treatments for chronic noninfectious uveitis.
Exploring Newer Strategies for Treating Chronic Noninfectious Uveitis: A Mix and Match Approach
This session will examine the evidence for biologic immunomodulatory agents and intravitreal treatments for chronic noninfectious uveitis.
Emerging Treatments in Geographic Atrophy: Reason for Hope?
UPDATED TO REFLECT THE LATEST FDA APPROVALS. This session will review the QoL impact of GA and examine current and emerging treatment approaches.
Overcoming Adherence Challenges in Neovascular AMD: Exploring Variable Dosing Strategies and New Treatment Pathways and Delivery Systems
UPDATED TO REFLECT THE LATEST FDA APPROVALS. This session will review current treatment challenges for nAMD and strategies for overcoming them.
Optimizing Intravitreal Pharmacotherapies for Diabetic Macular Edema
UPDATED TO REFLECT THE LATEST FDA APPROVALS. This session will review care disparities in DME and provide an overview of current and emerging treatments.
Experts Publish First Guidance on Use of Teprotumumab for Thyroid Eye Disease
This news-based activity will review recommendations from an expert panel on the use of teprotumumab, the only FDA-approved disease-modifying therapy for TED.
Informatics Study Reveals Real-World Outcomes for Glaucoma Filtration Surgery: Implications for Clinical Practice
This news-based activity will review the use of a health informatics approach to understand real-world outcomes for glaucoma filtration surgery.